“Latest evidence favours metformin over glibenclamide, but there’s more work to do on both agents.”
Read all about it in The BMJ
Editorial by David Sacks, BMJ 2015;350:h177.
Systematic review and meta-analysis by Montserrat Balsells et al., BMJ 2015;350:h102
Endodiabesity 